FOXO1 is an essential regulator of pluripotency in human embryonic stem cells

Zhang, Xin; Yalcin, Safak; Lee, Dung-Fang; Yeh, Tsung-Yin J.; Lee, Seung-Min; Su, Jie; Mungamuri, Sathish Kumar; Rimmel�, Pauline; Kennedy, Marion; Sellers, Rani; Landthaler, Markus; Tuschl, Thomas; Chi, Nai-Wen; Lemischka, Ihor; Keller, Gordon; Ghaffari, Saghi
September 2011
Nature Cell Biology;Sep2011, Vol. 13 Issue 9, p1092
Academic Journal
Pluripotency of embryonic stem cells (ESCs) is defined by their ability to differentiate into three germ layers and derivative cell types and is established by an interactive network of proteins including OCT4 (also known as POU5F1; ref. ), NANOG (refs , ), SOX2 (ref. ) and their binding partners. The forkhead box O (FoxO) transcription factors are evolutionarily conserved regulators of longevity and stress response whose function is inhibited by AKT protein kinase. FoxO proteins are required for the maintenance of somatic and cancer stem cells; however, their function in ESCs is unknown. We show that FOXO1 is essential for the maintenance of human ESC pluripotency, and that an orthologue of FOXO1 (Foxo1) exerts a similar function in mouse ESCs. This function is probably mediated through direct control by FOXO1 of OCT4 and SOX2 gene expression through occupation and activation of their respective promoters. Finally, AKT is not the predominant regulator of FOXO1 in human ESCs. Together these results indicate that FOXO1 is a component of the circuitry of human ESC pluripotency. These findings have critical implications for stem cell biology, development, longevity and reprogramming, with potentially important ramifications for therapy.


Related Articles

  • Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells. Ran Wang; Shuxun Chen; Changxian Li; Kevin Tak Pan Ng; Chi-wing Kong; Jinping Cheng; Shuk Han Cheng; Li, Ronald A.; Chung Mau Lo; Kwan Man; Dong Sun // BMC Cancer;2/4/2016, Vol. 16, p1 

    Background: Cell fusion is a fast and highly efficient technique for cells to acquire new properties. The fusion of somatic cells with stem cells can reprogram somatic cells to a pluripotent state. Our research on the fusion of stem cells and cancer cells demonstrates that the fused cells can...

  • Association of telomere length with authentic pluripotency of ES/iPS cells. Junjiu Huang; Fang Wang; Okuka, Maja; Na Liu; Guangzhen Ji; Xiaoying Ye; Bingfeng Zuo; Minshu Li; Ping Liang; Ge, William W.; Tsibris, John C. M.; Keefe, David L.; Lin Liu // Cell Research;May2011, Vol. 21 Issue 5, p779 

    Telomerase and telomeres are important for indefinite replication of stem cells. Recently, telomeres of somatic cells were found to be reprogrammed to elongate in induced pluripotent stem cells (iPSCs). The role of telomeres in developmental pluripotency in vivo of embryonic stem cells (ESCs) or...

  • Putting induced pluripotent stem cells to the test. Vallier, Ludovic // Nature Biotechnology;Nov2015, Vol. 33 Issue 11, p1145 

    The article focuses on the sustainability of Human induced pluripotent stem cells (hiPSCs) for supporting clinical applications. Topics discussed include new possibilities for personalized cell therapy after the discovery that human somatic cell can be reprogrammed into a pluripotent stem cell,...

  • Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Yingzi Oh; Heming Wei; Dongrui Ma; Xiaoming Sun; Liew, Reginald // Heart;Mar2012, Vol. 98 Issue 6, p443 

    The emergence of induced pluripotent stem cell (iPSC) technology has had a great impact on the field of medicine ever since the ground-breaking discovery in 2006 that overexpression of four specific transcription factors was able to turn back the developmental clock of somatic cells into an...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Differential Coupling of Self-Renewal Signaling Pathways in Murine Induced Pluripotent Stem Cells. Orlando, Luca; Sanchez-Ripoll, Yolanda; Foster, James; Bone, Heather; Giachino, Claudia; Welham, Melanie J. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs), exhibiting properties similar to those of embryonic stem cells (ESCs), has attracted much attention, with many studies focused on improving efficiency of derivation and unraveling the mechanisms of reprogramming....

  • Human induced pluripotent stem cells-from mechanisms to clinical applications. Drews, Katharina; Jozefczuk, Justyna; Prigione, Alessandro; Adjaye, James // Journal of Molecular Medicine;Jul2012, Vol. 90 Issue 7, p735 

    Human pluripotent stem cells hold great promise for basic research and regenerative medicine due to their inherent property to propagate infinitely, while maintaining the potential to differentiate into any given cell type of the human body. Since the first derivation in 1998, pluripotent human...

  • Uses of cardiomyocytes generated from induced pluripotent stem cells. Tung-Ying Lu; Lei Yang // Stem Cell Research & Therapy;2011, Vol. 2 Issue 6, p1 

    Embryonic stem (ES) cells are naturally derived from early stage embryos and induced pluripotent stem (iPS) cells are reprogrammed from somatic cells with overexpression of four reprogramming factors, Oct4, Sox2, Klf4 and c-Myc. Both ES cells and iPS cells are pluripotent stem cells with...

  • Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Awe, Jason P.; Lee, Patrick C.; Ramathal, Cyril; Vega-Crespo, Agustin; Durruthy-Durruthy, Jens; Cooper, Aaron; Karumbayaram, Saravanan; Lowry, William E.; Clark, Amander T.; Zack, Jerome A.; Sebastiano, Vittorio; Kohn, Donald B.; Pyle, April D.; Martin, Martin G.; Lipshutz, Gerald S.; Phelps, Patricia E.; Pera, Renee A. Reijo; Byrne, James A. // Stem Cell Research & Therapy;2013, Vol. 4 Issue 4, p1 

    Introduction: The reprogramming of a patient's somatic cells back into induced pluripotent stem cells (iPSCs) holds significant promise for future autologous cellular therapeutics. The continued presence of potentially oncogenic transgenic elements following reprogramming, however, represents a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics